Yuvraj

The French pharma giant, Sanofi, has started a $15.50 per share cash tender offer when it comes to Emeryville, California-based vaccine developer Dynavax, which...

Laboratory automation and robotics are redefining pharmaceutical R&D by eliminating manual errors, enabling high-throughput screening, and freeing scientists to focus on innovation through "lights-out" operations.

While continuous manufacturing offers efficiency and quality benefits, high capital costs and technical barriers like PAT integration, feeder accuracy, and RTD modeling slow its widespread adoption in pharma.

AstraZeneca has gone ahead and committed $100 million to head deeper into the KRAS space by way of securing the right when it comes...

Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.

Connected equipment ecosystems revolutionize pharmaceutical operations by integrating AI-driven analytics, digital twins, and seamless middleware to enhance visibility, collaboration, and decision-making across the value chain.

Digital calibration and predictive maintenance use IoT and AI to transform lab asset management, shifting from reactive repairs to proactive strategies that ensure data integrity and maximize uptime.